Advertisement Ipca acquires Onyx Research Chemicals - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Ipca acquires Onyx Research Chemicals

Ipca Laboratoies UK, a wholly-owned subsidiary of Mumbai-based Ipca Laboratories Ltd, has acquired 100% stake in UK based Onyx Scientific holding company Onyx Research Chemicals for £4.6m (INR340m).

Onyx Scientific, a chemistry solutions provider to pharma and biotech companies, will continue to operate out of its Silverbriar facility (Sunderland, UK) under the Onyx Scientific trade name.

The company’s capabilities in chemistry services for medicinal, pre-clinical and Phase I/II programmes will dovetail Ipca’s capacity in supporting the scale up of programmes from the second phase of clinical trials to commercialization.

Onyx offers custom synthesis, solid state chemistry, scale up and cGMP manufacturing up to a few kilogram levels.